Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Delphinidin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.30 |
| ▸ | GLO1 | Q04760 | 6/20 | 1.00 |
| ▸ | SNCA | P37840 | 4/20 | 1.00 |
| ▸ | EGFR | P00533 | 2/20 | 1.00 |
| ▸ | KDR | P35968 | 2/20 | 1.00 |
| ▸ | EP300 | Q09472 | 2/20 | 1.00 |
| ▸ | CREBBP | Q92793 | 2/20 | 1.00 |
| ▸ | CD38 | P28907 | 12/20 | 0.97 |
| ▸ | DPP4 | P27487 | 4/20 | 0.71 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.71 |
| ▸ | F2 | P00734 | 1/20 | 0.69 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.69 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.69 |
| ▸ | MAOA | P21397 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Delphinidin SCHEMBL22369 | 1.00 | GLO1 (1.00) | GLO1SNCAEGFRKDREP300 | |
| Delphinidin SCHEMBL157864 | 0.98 | GLO1 (0.97) | GLO1SNCAEGFRKDREP300 | |
| Delphinidin SCHEMBL22370 | 0.98 | CD38 (1.00) | GLO1SNCAEGFRKDREP300 | |
| Petunidin SCHEMBL8411777 | 0.89 | CD38 (0.95) | GLO1SNCAEGFRKDREP300 | |
| Delphinidin SCHEMBL9063189 | 0.88 | CD38 (0.86) | GLO1SNCAEGFRKDREP300 | |
| Petunidin SCHEMBL21649 | 0.87 | CD38 (0.97) | GLO1SNCAEGFRKDREP300 | |
| Petunidin SCHEMBL29947229 | 0.87 | CD38 (0.97) | GLO1SNCAEGFRKDREP300 | |
| Petunidin SCHEMBL30683343 | 0.87 | CD38 (0.97) | GLO1SNCAEGFRKDREP300 | |
| Petunidin SCHEMBL9120043 | 0.85 | CD38 (0.95) | GLO1SNCAEGFRKDREP300 | |
| Petunidin SCHEMBL21650 | 0.85 | CD38 (1.00) | GLO1SNCAEGFRKDREP300 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117736980-B | Induced differentiation medium for transforming adipose-derived mesenchymal stem cells into chondrocytes and application thereof | 广东先康达生物科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117736980-A | Induced differentiation medium for transforming adipose-derived mesenchymal stem cells into chondrocytes and application thereof | 广东先康达生物科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| EP-2841109-B1 | PRODRUGS OF HYDROXYL-COMPRISING DRUGS | ASCENDIS PHARMA AS (DK) | 2026-04-15 | — | — | EP | disclosed |
| CN-118615267-A | New use of small molecule medicine in inhibiting coronavirus | 成都融昶生物科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-117736980-B | Induced differentiation medium for transforming adipose-derived mesenchymal stem cells into chondrocytes and application thereof | 广东先康达生物科技有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117736980-B | Induced differentiation medium for transforming adipose-derived mesenchymal stem cells into chondrocytes and application thereof | 广东先康达生物科技有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117736980-A | Induced differentiation medium for transforming adipose-derived mesenchymal stem cells into chondrocytes and application thereof | 广东先康达生物科技有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117736980-A | Induced differentiation medium for transforming adipose-derived mesenchymal stem cells into chondrocytes and application thereof | 广东先康达生物科技有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-111246873-B | Optimized peptides for targeting human nerves and their use in image guided surgery, diagnosis and therapy delivery | 加利福尼亚大学董事会 | 2024-03-01 | — | — | CN | disclosed |
| CN-114767794-B | Traditional Chinese medicine for treating arterial plaque | 海南万代兰生物医药科技有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-114767794-A | Traditional Chinese medicine for treating arterial plaque | 海南万代兰生物医药科技有限公司 | 2022-07-22 | — | — | CN | disclosed |